DNMT1 and Hepatic fibrosis: MiR-152 has been shown to downregulate DNMT1 expression, thereby reducing HSCs activation and ameliorating liver fibrosis by inhibiting PTCH1 methylation to enhance its expression and subsequently suppress the Hedgehog pathway [56].